Numerous studies on SMA undertaken primarily in connection with available or future therapies have provided the basis for the thesis that SMA is a multi-system disease [9,10] and that the SMN protein plays multiple roles in cell metabolism [11,12]. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.